• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病中的多个肾盂旁囊肿。

Multiple parapelvic cysts in Fabry disease.

作者信息

Azancot María A, Vila Josefa, Domínguez Carmen, Serres Xavier, Espinel Eugenia

机构信息

Servicio de Nefrología, Hospital Universitari Vall d'Hebron, Barcelona, España.

CIBBIM-Nanomedicina, Hospital Universitari Vall d'Hebron, Barcelona, España.

出版信息

Nefrologia. 2016 May-Jun;36(3):310-2. doi: 10.1016/j.nefro.2015.12.003. Epub 2016 Apr 6.

DOI:10.1016/j.nefro.2015.12.003
PMID:27061865
Abstract

Fabry disease is an inherited, X-linked lysosomal storage disorder caused by deficiency of the enzyme alpha galactosidase A (alpha-GLA A), which leads to glycosphingolipid accumulation, mainly globotriaosylceramide, in tissues. Disease prevalence and the index of suspicion are both low, which tends to result in delayed diagnosis and treatment. We present the case of a male Fabry disease patient who manifested no angiokeratoma lesions but presented multiple parapelvic cysts and renal failure. The genetic study revealed an alpha-GLA A gene mutation that had not been recorded in the mutations registry. The de novo mutation was not found in his relatives and it was not transmitted to his offspring. The large number and peculiar appearance of the parapelvic cysts led to the diagnosis.

摘要

法布里病是一种遗传性X连锁溶酶体贮积症,由α-半乳糖苷酶A(α-GLA A)缺乏引起,导致糖鞘脂在组织中蓄积,主要是球三糖神经酰胺。该病的患病率和疑似指数都很低,这往往导致诊断和治疗延迟。我们报告一例男性法布里病患者,该患者未出现血管角质瘤病变,但有多个肾盂旁囊肿和肾衰竭。基因研究发现了一个α-GLA A基因突变,该突变未记录在突变登记册中。该新生突变在其亲属中未发现,也未遗传给其后代。肾盂旁囊肿的数量众多且外观奇特,从而得以确诊。

相似文献

1
Multiple parapelvic cysts in Fabry disease.法布里病中的多个肾盂旁囊肿。
Nefrologia. 2016 May-Jun;36(3):310-2. doi: 10.1016/j.nefro.2015.12.003. Epub 2016 Apr 6.
2
De novo mutation in a male patient with Fabry disease: a case report.一名法布里病男性患者的新发突变:病例报告
BMC Res Notes. 2014 Jan 7;7:11. doi: 10.1186/1756-0500-7-11.
3
Fabry disease. A case report.法布里病。病例报告。
Acta Dermatovenerol Alp Pannonica Adriat. 2005 Mar;14(1):15-9.
4
Fabry disease in patients with end-stage renal failure: the potential benefits of screening.终末期肾衰竭患者的法布里病:筛查的潜在益处。
Nephron Clin Pract. 2005;101(1):c33-8. doi: 10.1159/000085709. Epub 2005 May 9.
5
Fabry disease: renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes.法布里病:患有经典型和心脏变异型表型的患病男性及携带者女性的肾脏超声和磁共振成像表现
J Comput Assist Tomogr. 2004 Mar-Apr;28(2):158-68. doi: 10.1097/00004728-200403000-00002.
6
Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.鉴定一种新型突变并对日本透析患者中的法布里病进行患病率研究。
Ren Fail. 2012;34(5):566-70. doi: 10.3109/0886022X.2012.669300.
7
Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.对一个有安德森-法布里病、新型 GLA 突变和严重心脏表型的大型西班牙家族进行全面的临床评估。
Med Clin (Barc). 2014 Jun 6;142(11):497-504. doi: 10.1016/j.medcli.2014.01.032. Epub 2014 Mar 26.
8
Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.患有法布里病和终末期肾衰竭的杂合子女性中的新型移码突变。
Am J Nephrol. 1996;16(4):352-7. doi: 10.1159/000169023.
9
Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.一名携带错义突变R118C的患者表现为左心室心尖肥厚的法布里病。
Rev Port Cardiol. 2014 Mar;33(3):183.e1-5. doi: 10.1016/j.repc.2013.11.005. Epub 2014 Mar 21.
10
Fabry disease: molecular genetics of the inherited nephropathy.法布里病:遗传性肾病的分子遗传学
Adv Nephrol Necker Hosp. 1989;18:113-27.

引用本文的文献

1
Fabry disease in the Spanish population: observational study with detection of 77 patients.西班牙人群中的法布里病:77 例患者的观察性研究。
Orphanet J Rare Dis. 2018 Apr 10;13(1):52. doi: 10.1186/s13023-018-0792-8.